Osustat 5mg Tablet contains Rosuvastatin, a potent HMG-CoA reductase inhibitor used primarily for the management of hyperlipidemia and the prevention of cardiovascular disease. Rosuvastatin works by inhibiting the enzyme responsible for cholesterol synthesis in the liver, leading to a significant reduction in low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels, while modestly increasing high-density lipoprotein cholesterol (HDL-C). Osustat is indicated for patients with primary hypercholesterolemia, mixed dyslipidemia, and familial hypercholesterolemia, as well as for the prevention of atherosclerotic cardiovascular disease in individuals at high risk. The recommended dosage of Osustat 5mg should be individualized based on patient response and lipid levels, with adjustments made under medical supervision. It is important to monitor liver function tests and creatine kinase levels periodically during therapy to detect potential adverse effects such as hepatotoxicity or myopathy. Osustat should be used in conjunction with a proper diet, exercise, and lifestyle modifications to achieve optimal lipid control. Caution is advised in patients with pre-existing liver disease, renal impairment, or those taking concomitant medications that may interact with Rosuvastatin. Regular follow-up with healthcare providers is essential to ensure efficacy and safety.